Gerrit Los

5.5k citations
95 papers · 4.2k · 2 hit papers · h-index 33

Impact in

  • Oncology top 2%
    • PARP inhibition in cancer therapy
    • Lung Cancer Research Studies
    • Ovarian cancer diagnosis and treatment

Papers in

    • DNA Repair Mechanisms 7
    • Cancer therapeutics and mechanisms 7
    • Melanoma and MAPK Pathways 6
    • HER2/EGFR in Cancer Research 7
    • Cancer Treatment and Pharmacology 5

Gerrit Los

94 papers receiving 4.0k citations

Gerrit Los's Hit Papers

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms 2007 · 596 citations
5960+6+12Years since publication100200300400500

Peers

Gerrit Los
Comparison fields: 5 of 117
  • Oncology 1.4k
  • Reproductive Medicine 369
  • Otorhinolaryngology 149
  • Hepatology 258
  • Pulmonary and Respiratory Medicine 882
Replace Tom Anderson with:
Tom Anderson United States
L B Grochow United States
Michele Orditura Italy
Kazuko Sakai Japan
E Reed United States
Ferdinando De Vita Italy
Geke A.P. Hospers Netherlands
Guido Bocci Italy
A. Hilary Calvert United Kingdom
James L. Speyer United States
Gerrit Los relative to Tom Anderson United States Tom Anderson's profile →
Citations per field
00.5×10.8×
Tom Anderson · 1×
Citations per year

Countries citing papers authored by Gerrit Los

Since Specialization
Citations

This map shows the geographic impact of Gerrit Los's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Los with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Los more than expected).

Fields of papers citing papers by Gerrit Los

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit Los. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Los. The network helps show where Gerrit Los may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerrit Los, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerrit Los Line = papers co-authored together Gerrit Los links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#Work
1
An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms
Hit paper breakdown →
2007596
2
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
Hit paper breakdown →
2007517
3 2010211
4 2010192
5 1991148
6 1994125
7
Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.
1989117
8 1990114
9 1994106
10 2005104
11 199198
12 200395
13 200992
14 201386
15
Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
198981
16 199977
17 199671
18
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
199262
19 201060
20 199759

About Gerrit Los

Gerrit Los is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 4.2k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (13 papers), Intraperitoneal and Appendiceal Malignancies (11 papers), DNA Repair Mechanisms (7 papers), HER2/EGFR in Cancer Research (7 papers), Cancer therapeutics and mechanisms (7 papers), Microtubule and mitosis dynamics (6 papers), Melanoma and MAPK Pathways (6 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Oncology (1.4k citations), Reproductive Medicine (369 citations), Otorhinolaryngology (149 citations), Hepatology (258 citations) and Pulmonary and Respiratory Medicine (882 citations). Gerrit Los has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include J. G. McVie, Maria E. Arango, James G. Christensen, Barbara Mroczkowski, P.H.A. Mutsaers, Shinji Yamazaki, Qiuhua Li, Joseph H. Lee, Helen Y. Zou and Gordon Alton. Their work appears in journals such as Cancer Research, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Molecular Cancer Therapeutics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact